from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1782/eccB5

LFCtreatmentdescriptionclass of inhibitor

-1.465

Amikacinug/mL Amikacintranslation

-0.162

Cap5-10ug/mL Capreomycintranslation

-0.621

Rox10-50 ug/mL Roxithromycintranslation

-0.486

SM2-5 ug/mL Streptomycintranslation

-0.878

Tet5-10 ug/mL Tetracyclinetranslation

-0.224

Rif0.2-5ug/mL Rifampicintranscription

-1.212

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.788

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.332

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.155

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.136

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.235

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.887

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.076

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.995

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.326

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.169

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.830

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.186

Nigericin50 uM Nigericinrespiration

0.806

TRC10-150 ug/mL Triclosanrespiration

0.879

TRZ10-25 ug/mL Thioridazinerespiration

-0.586

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.865

menadione6-10 ug/mL Menadionerespiration

0.637

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.700

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.043

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.252

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.496

NRP_1Non-replicating persistence stage 1dosRassociated

0.146

Amp0.2mg/mL AmpicillincellWall

0.357

Cephalexin20-100 ug/mL CephalexincellWall

0.016

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.175

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.248

EMB10-20 ug/mL EthambutolcellWall

0.148

Eta12-40 ug/mL EthionamidecellWall

-0.552

INH0.2-0.4 ug/mL IsoniazidcellWall

0.433

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.355

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.145

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.343

BZA0.12 mg/mL BenzamidearomaticAmides

-0.526

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.083

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.373

H2O24 mM hydrogen peroxideDNAdamaging

0.349

Levo10 ug/mL LevofloxacinDNAdamaging

0.443

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.354

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.115

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.055

UVUV-irradiationDNAdamaging

0.753

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.204

Antimycin12.5-50 ug/mL Antimycin A?

-2.507

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.329

PA_110-50 ug/mL Antitubercular compound PA-1?

0.353

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.208

PA8240.2-2 ug/mL PA-824?

0.012

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.650

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-2.708

Verapamil50 uM Verapamil?

-2.057

mercaptoethanol2 mM 2-Mercaptoethanol?

0.561

methoxatin10-20 ug/mL Methoxatin?